PRT 062070 (Cerdulatinib)

Catalog No. A14147

PRT 062070 (Cerdulatinib)是一种新型的口服双脾酪氨酸激酶(Syk)和janus激酶(JAK)抑制剂。Cerdulatinib优先抑制各种细胞类型中JAK1和JAK3依赖性细胞因子介导的信号传导和功能性反应。
Catalog Num A14147
M. Wt 445.54
Formula C20H27N7O3S
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 1198300-79-6
Synonyms Cerdulatinib,PRT2070,PRT-2070,PRT 2070,PRT-062070,PRT062070
SMILES CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N
PRT 062070 (Cerdulatinib)是一种新型的口服双脾酪氨酸激酶(Syk)和janus激酶(JAK)抑制剂。Cerdulatinib优先抑制各种细胞类型中JAK1和JAK3依赖性细胞因子介导的信号传导和功能性反应。
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 22.44 mL 112.22 mL 224.45 mL
0.5 mM 4.49 mL 22.44 mL 44.89 mL
1 mM 2.24 mL 11.22 mL 22.44 mL
5 mM 0.45 mL 2.24 mL 4.49 mL

*The above data is based on the productmolecular weight 445.54. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.